Premium Information is available for this item - Upgrade for $1 a day
6505-00-086-1542
Usp Levothyroxine Sodium Tablets
6505000861542 000861542 SYNTHR0ID
November 2023
9

Marketplace 6505-00-086-1542
Request a Quotation from participating marketplace vendors
Related Documents 6505-00-086-1542 5+ Documents (More...)
/fsg-65/fsc-6505/us 6505-00-086-1542 Sodium Tablets 000861542 RQST Usp Levothyroxine Sodium Tablets
000861542 Levothyroxine Sodium Tablets Usp Levothyroxine Sodium Tablets 000861542 6505/us 6505-00-086
Usp Levothyroxine Sodium Tablets 000861542 6505-00-086-1542 Usp Levothyroxine Sodium Tablets https
6505123446761 6505190005136 Levothyroxine Sodium Tablets 6505123446761 Levothyroxine Sodium Tablets 000861542
Tablets 6505123446761 6505/us 6505-00-227-9826 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-086-1542
Usp Levothyroxine Sodium Tablets 000861542 Upgrade your Account Upgrade 6505-00-086-1542Usp Levothyroxine
Usp Levothyroxine Sodium Tablets 000861542 6505/us 6505-00-086-1542 Usp Levothyroxine Sodium Tablets
000861542 Levothyroxine Sodium Tablets 010279055 Account Upgrade 6505-00-086-1542Usp Levothyroxine https
Usp Levothyroxine Sodium Tablets 000861542 -086- https Sodium Tablets 6505123446761 https https
Usp Levothyroxine Sodium Tablets 009151630 /www.nsnlookup.com /fsg-65/fsc-6505/br 6505-19- https 000861542
Restrictions 6505-00-086-1542
6505-00-086-1542 is a Usp Levothyroxine Sodium Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
End Users 6505-00-086-1542
- NASA (G57V)
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-00-086-1542
- Part Number
- Manufacturer
- Status
- SYNTHR0ID
- Manufacturer
- 04687 - Baxter Healthcare Corp (Active)
- Incomplete Reference
- Incomplete Reference
Datasheet 6505-00-086-1542
- Characteristic
- Specifications
- Active Medicament Medicinal Strength [AKJA]
- Specifications
- 0.100 Milligrams Levothyroxine Sodium Active Ingredient
- Administration [CSGS]
- Oral
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 500.000 Tablets
NATO Stock Numbers Related to 6505-00-086-1542
Freight Information 6505-00-086-1542
6505-00-086-1542 has freight characteristics.. 6505-00-086-1542 has a variance between NMFC and UFC when transported by rail and the description should be consulted.